593 Treating chronic hepatitis C with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin in routine clinical practice: Factors predicting SVR using multiple logistic regression analysis
Lee, S.S., Powis, J., Heathcote, E.J., Sherman, M., Bailey, R.J., Feinman, S.V., Baro, V., Yoshidas, E., Witt-Sullivan, H.B., Peltekian, K.
Published in Journal of hepatology (01.04.2006)
Published in Journal of hepatology (01.04.2006)
Get full text
Journal Article